Mental Health & Behavioral Research | Obesity & Weight Control, Phase I-II

GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight

Volunteers
Health Professionals

What is the purpose of this trial?

If you are between 18 and 55 years of age and are overweight or have obesity you may qualify for a clinical trial evaluating a once weekly medication which may help with weight loss. The SEMA trial is funded by the National Institutes of Health (NIH) and the study medication (semaglutide vs. placebo) is provided at no cost to qualifying participants. Participants with diabetes are not eligible for this study.

Trial with
National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
Ages
18 years - 55 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Rachel Hart

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Ania Jastreboff, MD, PhD
Associate Professor of Medicine (Endocrinology); Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management; Medical Director, Yale Stress Center

Sub-Investigators

Last Updated
10/16/2024
Study HIC
#2000027868